Literature DB >> 31395388

Upcoming Scenarios for the Comprehensive Management of Obstructive Sleep Apnea: An Overview of the Spanish Sleep Network.

Olga Mediano1, Irene Cano-Pumarega2, Manuel Sánchez-de-la-Torre3, María Luz Alonso-Álvarez4, María Fernanda Troncoso5, Francisco García-Río6, Carlos Egea7.   

Abstract

Sleep is considered an essential part of life and plays a vital role in good health and well-being. Equally important as a balanced diet and adequate exercise, quality and quantity of sleep are essential for maintaining good health and quality of life. Sleep-disordered breathing is one of the most prevalent conditions that compromises the quality and duration of sleep, with obstructive sleep apnea (OSA) being the most prevalent disorder among these conditions. OSA is a chronic and highly prevalent disease that is considered to be a true public health problem. OSA has been associated with increased cardiovascular, neurocognitive, metabolic and overall mortality risks, and its management is a challenge facing the health care system. To establish the main future lines of research in sleep respiratory medicine, the Spanish Sleep Network (SSN) promoted the 1st World Café experts' meeting. The overall vision was established by consensus as "Sleep as promoter of health and the social impact of sleep disturbances". Under this leitmotiv and given that OSA is the most prevalent sleep disorder, five research lines were established to develop a new comprehensive approach for OSA management: (1) an integrated network for the comprehensive management of OSA; (2) the biological impact of OSA on comorbidities with high mortality, namely, cardiovascular and metabolic diseases, neurocognitive diseases and cancer; (3) Big Data Analysis for the identification of OSA phenotypes; (4) personalized medicine in OSA; and (5) OSA in children: current needs and future perspectives.
Copyright © 2019 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Clinical management; Continuous positive airway pressure; Manejo clínico; Medicina personalizada; Obstructive sleep apnea; Personalized medicine; Presión positiva continua en la vía aérea; Síndrome de la apnea obstructiva del sueño

Mesh:

Year:  2019        PMID: 31395388     DOI: 10.1016/j.arbres.2019.05.017

Source DB:  PubMed          Journal:  Arch Bronconeumol (Engl Ed)        ISSN: 0300-2896            Impact factor:   4.872


  1 in total

1.  Giant Lung Herniation After Minimally Invasive Cardiac Surgery.

Authors:  Blanca Meana; Daniel Hernandez-Vaquero; Jacobo Silva
Journal:  Arch Bronconeumol (Engl Ed)       Date:  2018-03-05       Impact factor: 4.872

  1 in total
  3 in total

1.  Respiratory Polygraphy Patterns and Risk of Recurrent Cardiovascular Events in Patients With Acute Coronary Syndrome.

Authors:  Andrea Zapater; Geoffroy Solelhac; Alicia Sánchez-de-la-Torre; Esther Gracia-Lavedan; Ivan David Benitez; Gerard Torres; Jordi De Batlle; José Haba-Rubio; Mathieu Berger; Jorge Abad; Joaquín Duran-Cantolla; Amaia Urrutia; Olga Mediano; María José Masdeu; Estrella Ordax-Carbajo; Juan Fernando Masa; Mónica De la Peña; Mercé Mayos; Ramon Coloma; Josep María Montserrat; Eusebi Chiner; Olga Mínguez; Lydia Pascual; Anunciación Cortijo; Dolores Martínez; Mireia Dalmases; Chi-Hang Lee; R Doug McEvoy; Ferran Barbé; Raphael Heinzer; Manuel Sánchez-de-la-Torre
Journal:  Front Med (Lausanne)       Date:  2022-06-27

Review 2.  Obstructive Sleep Apnea: Emerging Treatments Targeting the Genioglossus Muscle.

Authors:  Olga Mediano; Sofia Romero-Peralta; Pilar Resano; Irene Cano-Pumarega; Manuel Sánchez-de-la-Torre; María Castillo-García; Ana Belén Martínez-Sánchez; Ana Ortigado; Francisco García-Río
Journal:  J Clin Med       Date:  2019-10-22       Impact factor: 4.241

3.  Endogenous controls and microRNA profile in female patients with obstructive sleep apnea.

Authors:  Andrea Zapater; Iván D Benítez; Fernando Santamaria-Martos; Lucía Pinilla; Adriano Targa; David De Gonzalo-Calvo; Gerard Torres; Olga Mínguez; Anunciación Cortijo; Mireia Dalmases; Ferrán Barbé; Manuel Sánchez-de-la-Torre
Journal:  Sci Rep       Date:  2022-02-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.